Arterys, a medical imaging software developer for clinical AI products, announced today that it raised $28 million in a Series C financing round.
Benslie Investment Group and Temasek Holdings led the funding, while Fosun, Revelation Partners, Emergent Medical Partners and Varian Medical Systems participated as well.
San Francisco-based Arterys said in a news release that it intends to use the funds to broaden its ecosystem, which includes a broad set of partners on its new marketplace that utilizes its cloud platform.
Much focus will gear toward accelerating partners’ efforts to bring new, clinical-grade AI applications to providers by extending the Arterys technology platform to application partners so they can integrate AI into their workflows, the company said.
Additionally, Arterys appointed co-founder John Axerio-Cilies as its acting CEO. According to a previous press release, Axerio-Cilies previously held the role of chief tech…